Navigation Links
Quest Diagnostics Is Named 'Best Employer For Healthy Lifestyles'
Date:5/13/2008

Company's "Biggest Loser" Bill Germanakos to Deliver NBGH Keynote Address

MADISON, N.J., May 13 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the leading provider of diagnostic testing, information and services, announced today that the National Business Group on Health (NBGH), an association of more than 300 large U.S. employers, has presented its 2008 Best Employers for Healthy Lifestyles Gold Award to the company for its HealthyQuest employee wellness program. In its second consecutive year as Gold Award recipient, Quest Diagnostics is one of only seven companies to have received the NBGH Healthy Lifestyles awards in the four years the awards have been given. The company was honored with the Silver Award in 2006 and 2005.

Bill Germanakos, director of Employer Wellness Initiatives at Quest Diagnostics will deliver a keynote address at today's NBGH awards ceremony. Mr. Germanakos was last season's winner on the NBC television program The Biggest Loser(R). He lost 164 pounds -- or 49.1 percent of his body weight -- in 34 weeks, dramatically improving his health. In his keynote address, Germanakos will talk about the events that led to his participation in the show, and the profound impact becoming "The Biggest Loser" has had on his health.

"We are very pleased to honor Quest Diagnostics for their innovation and commitment to providing lifestyle improvement programs designed to encourage healthier lifestyles for their employees," said Helen Darling, president of NBGH. "Quest Diagnostics and its management team should be proud of both their initiatives and ongoing support of helping employees to choose a healthier way of life."

Quest Diagnostics HealthyQuest provides employees and their spouse
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
2. The 7 Key Questions About the Schwarzenegger/Nunez Health Care Compromise
3. LifeQuest Announces End of Immunity Health Challenge Contest
4. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
5. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
6. Study Questions Dead-End Cancer Clinical Trials
7. 6 Years Later, 9/11 Health Questions Linger
8. U.S. Physicians Question Presidential Candidates
9. RFID Implant Cancer Questions Concern Patients
10. Study Questions Genetic Screening for Treatable Diseases
11. Mass. Judge Denies Request by Breastfeeding Mother for More Break Time on Medical Licensing Exam
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 2ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference 3Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 1Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 2Masimo to Report Second Quarter 2009 Financial Results on August 4 2009 52366 3Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 1Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 2Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 3Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 4Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 5Nexavar in Combination with Chemotherapy Shown to Extend Progression Free Survival in Patients with Advanced Breast Cancer 52362 6NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 1NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 2NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 3NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 4NBTY Acquisition of Julian Graves Unconditionally Cleared 52360 5